Assertio Holdings Inc ASRT:NASDAQ

RT Quote | NASDAQ | USD
Last | 05/19/22 EDT
3.13quote price arrow up+0.20 (+6.83%)
Volume
1,289,074
52 week range
0.85 - 3.52
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close3.13
  • 52 Week High3.52
  • 52 Week High Date04/11/22
  • 52 Week Low0.85
  • 52 Week Low Date10/06/21

Key Stats

  • Market Cap142.20M
  • Shares Out45.43M
  • 10 Day Average Volume1.11M
  • Dividend-
  • Dividend Yield-
  • Beta1.40
  • YTD % Change43.58

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close3.13
  • 52 Week High3.52
  • 52 Week High Date04/11/22
  • 52 Week Low0.85
  • 52 Week Low Date10/06/21
  • Market Cap142.20M
  • Shares Out45.43M
  • 10 Day Average Volume1.11M
  • Dividend-
  • Dividend Yield-
  • Beta1.40
  • YTD % Change43.58

RATIOS/PROFITABILITY

  • EPS (TTM)-0.01
  • P/E (TTM)-230.15
  • Fwd P/E (NTM)11.18
  • EBITDA (TTM)40.087M
  • ROE (TTM)-1.62%
  • Revenue (TTM)111.01M
  • Gross Margin (TTM)86.19%
  • Net Margin (TTM)-1.15%
  • Debt To Equity (MRQ)71.76%

EVENTS

  • Earnings Date08/03/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Assertio Holdings Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Assertio Holdings, Inc. is a specialty pharmaceutical company offering differentiated products to patients utilizing a non-personal promotional model. The Company's primary marketed products are INDOCIN (indomethacin) Suppositories, INDOCIN (indomethacin) Oral Suspension, INDOCIN (indomethacin) Oral Suspension, CAMBIA (diclofenac potassium for oral solution), Otrexup (methotrexate) injection for subcutaneous use, SPRIX (ketorolac tromethamine) Nasal Spray and Zipsor...
Peter Staple
Independent Chairman of the Board
Daniel Peisert
President, Chief Executive Officer, Director
Paul Schwichtenberg
Chief Financial Officer, Senior Vice President
Address
100 S. Saunders Road, Suite 300
Lake Forest, IL
60045
United States

Top Peers

SYMBOLLASTCHG%CHG
PRTK
Paratek Pharmaceuticals Inc
1.90-0.06-3.06%
OPTN
OptiNose Inc
1.96-0.03-1.51%
ACOR
Acorda Therapeutics Inc
0.5546-0.0246-4.2472%
HROW
Harrow Health Inc
5.77+0.02+0.35%
CDXC
Chromadex Corp
1.76+0.03+1.73%